Mangoceuticals (MGRX) Gross Profit (2023 - 2025)
Mangoceuticals' Gross Profit history spans 3 years, with the latest figure at $47475.0 for Q4 2025.
- On a quarterly basis, Gross Profit fell 40.73% to $47475.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $250386.0, a 34.1% decrease, with the full-year FY2025 number at $250386.0, down 34.1% from a year prior.
- Gross Profit hit $47475.0 in Q4 2025 for Mangoceuticals, down from $50899.0 in the prior quarter.
- Over the last five years, Gross Profit for MGRX hit a ceiling of $147398.0 in Q1 2024 and a floor of $47475.0 in Q4 2025.
- Historically, Gross Profit has averaged $88487.6 across 3 years, with a median of $81387.0 in 2024.
- Biggest five-year swings in Gross Profit: soared 157.69% in 2024 and later plummeted 57.89% in 2025.
- Tracing MGRX's Gross Profit over 3 years: stood at $142583.0 in 2023, then plummeted by 43.82% to $80103.0 in 2024, then crashed by 40.73% to $47475.0 in 2025.
- Business Quant data shows Gross Profit for MGRX at $47475.0 in Q4 2025, $50899.0 in Q3 2025, and $89948.0 in Q2 2025.